Evidence map›Paper›PMID 26529596›Full record

ArticlePloS one2015

A Reevaluation of the Voluntary Medical Male Circumcision Scale-Up Plan in Zimbabwe.

Susanne F Awad, Sema K Sgaier, Gertrude Ncube, Sinokuthemba Xaba, Owen M Mugurungi, Mutsa M Mhangara, Fiona K Lau, Yousra A Mohamoud, Laith J Abu-Raddad

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Does infection withSexually transmitted infections · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Circumcision and its effects in Africa.Translational andrology and urology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Susanne F AwadInfectious Disease Epidemiology Group, Weill Cornell Medical College in Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
Sema K SgaierIntegrated Delivery, Global Development Program, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Gertrude NcubeAIDS and TB Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
Sinokuthemba XabaAIDS and TB Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
Owen M MugurungiAIDS and TB Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
Mutsa M MhangaraAIDS and TB Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
Fiona K LauIntegrated Delivery, Global Development Program, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Yousra A MohamoudInfectious Disease Epidemiology Group, Weill Cornell Medical College in Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medical College in Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar; Department of Healthcare Policy and Research, Weill Cornell Medical College, Cornell University, New York, New York, United States of America; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe voluntary medical male circumcision (VMMC) program in Zimbabwe aims to circumcise 80% of males aged 13-29 by 2017. We assessed the impact of actual VMMC scale-up to date and evaluated the impact of potential alterations to the program to enhance program efficiency, through prioritization of subpopulations. METHODS AND

findingsWe implemented a recently developed analytical approach: the age-structured mathematical (ASM) model and accompanying three-level conceptual framework to assess the impact of VMMC as an intervention. By September 2014, 364,185 males were circumcised, an initiative that is estimated to avert 40,301 HIV infections by 2025. Through age-group prioritization, the number of VMMCs needed to avert one infection (effectiveness) ranged between ten (20-24 age-group) and 53 (45-49 age-group). The cost per infection averted ranged between $811 (20-24 age-group) and $5,518 (45-49 age-group). By 2025, the largest reductions in HIV incidence rate (up to 27%) were achieved by prioritizing 10-14, 15-19, or 20-24 year old. The greatest program efficiency was achieved by prioritizing 15-24, 15-29, or 15-34 year old. Prioritizing males 13-29 year old was programmatically efficient, but slightly inferior to the 15-24, 15-29, or 15-34 age groups. Through geographic prioritization, effectiveness varied from 9-12 VMMCs per infection averted across provinces. Through risk-group prioritization, effectiveness ranged from one (highest sexual risk-group) to 60 (lowest sexual risk-group) VMMCs per infection averted.

conclusionThe current VMMC program plan in Zimbabwe is targeting an efficient and impactful age bracket (13-29 year old), but program efficiency can be improved by prioritizing a subset of males for demand creation and service availability. The greatest program efficiency can be attained by prioritizing young sexually active males and males whose sexual behavior puts them at higher risk for acquiring HIV.

Indexed as

Circumcision, MaleNational Health ProgramsProgram EvaluationAdolescentAdultCost-Benefit AnalysisHIV InfectionsHumansIncidenceMaleMiddle AgedModels, TheoreticalMultivariate AnalysisSexual BehaviorUncertaintyYoung Adult

Identifiers

PMID26529596
PMCPMC4646702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.